Nav: Home

Drug-delivering device streamlines tuberculosis treatment in pigs

March 13, 2019

Scientists have created a retrievable, wire-like device that safely resides in the stomach and releases large dosages of drugs over several weeks. The new delivery system, which was successfully tested in pigs, could help patients in remote and underserved geographic areas adhere to drug treatments for infectious diseases such as tuberculosis (TB) that are currently treated with burdensome amounts of oral medications. TB represents one of the most widespread and devastating infectious diseases today, causing approximately 10 million cases worldwide in 2017. Most cases of TB can be effectively treated with oral antibiotics, but most therapies involve multiple drugs administered in large doses for up to several months. (An average 60 kg patient requires 3.3 grams of antibiotics a day.) Following such treatment regimens can be challenging for patients (previous research reports that 50% of patients experience difficulty sticking to treatment recommendations), especially in developing regions that lack adequate healthcare resources. As a result, poor patient adherence to treatments has become a major contributor to treatment failure and the emergence of drug-resistant TB strains. To meet the need for a more practical delivery system, Malvika Verma and colleagues developed a new platform consisting of bead-like drug pills housed on a flexible wire that can be deployed to the stomach through the esophagus in 60 seconds. The researchers studied their device in healthy pigs and found that it safely released the standard TB antibiotics rifampicin over one week and doxycycline hyclate over four weeks, and was easily retrieved via a nasogastric tube after the treatment was completed. Importantly, a questionnaire of 111 TB health care providers and 300 patients with TB in India showed that a long-term nasogastric drug delivery system was considered feasible on the ground, and an established model predicted that such a device could result in over $8,000 in savings per patient.
-end-


American Association for the Advancement of Science

Related Tuberculosis Articles:

Old target, new mechanism for overcoming tuberculosis resistance
In strains of tuberculosis that have developed drug resistance mutations, researchers have identified a secondary pathway that can be activated to reinstate drug sensitivity.
Researchers use tiny 3-D spheres to combat tuberculosis
Researchers at the University of Southampton have developed a new 3-D system to study human infection in the laboratory.
How the tuberculosis vaccine may protect against other diseases
The tuberculosis vaccine is well known to help protect against other infectious diseases, as well as cancer, but the exact mechanisms have not been clear.
Tuberculosis bacteria find their ecological niche
An international team of researchers have isolated and analyzed genetically tuberculosis bacteria from several thousand patients from over a hundred countries.
Tuberculosis and HIV co-infection
The HIV virus increases the potency of the tuberculosis bacterium (Mtb) by affecting a central function of the immune system.
More Tuberculosis News and Tuberculosis Current Events

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Teaching For Better Humans
More than test scores or good grades — what do kids need to prepare them for the future? This hour, guest host Manoush Zomorodi and TED speakers explore how to help children grow into better humans, in and out of the classroom. Guests include educators Olympia Della Flora and Liz Kleinrock, psychologist Thomas Curran, and writer Jacqueline Woodson.
Now Playing: Science for the People

#535 Superior
Apologies for the delay getting this week's episode out! A technical glitch slowed us down, but all is once again well. This week, we look at the often troubling intertwining of science and race: its long history, its ability to persist even during periods of disrepute, and the current forms it takes as it resurfaces, leveraging the internet and nationalism to buoy itself. We speak with Angela Saini, independent journalist and author of the new book "Superior: The Return of Race Science", about where race science went and how it's coming back.